Nephrectomy, Prostatectomy
Conditions
Keywords
Radical nephrectomy, Partial nephrectomy, Radical prostatectomy, Lymphadenectomy, Lysis of adhesions, Robotic surgery, Minimal invasive surgery, Robotic minimal invasive surgery, Urology
Brief summary
The purpose of this clinical investigation was to evaluate the safety and performance of the Bitrack System and its corresponding ElectroSurgical Endoscopic (ESE) instruments and Non-ElectroSurgical Endoscopic (NESE) instruments and accessories in patients with the indication of a robot assisted laparoscopic Radical Nephrectomy (RN), Partial Nephrectomy (PN) or Radical Prostatectomy (RP), as applicable.The HYROS-PRnP study served as a confirmatory investigation, with the primary endpoint hypothesis centered around the effective performance of the Bitrack System and the ESE/NESE instruments and accessories as intended by the surgeon during the intervention.This study included the data collected up to 30 days post-surgery and provided the evidence that the tested medical devices fulfill the GSPR.
Detailed description
The Bitrack System is first 4-arms on demand open robotic platform indicated to be used during general abdominal laparoscopic urologic surgical procedures. This robot is intended to assist in the accurate control of endoscopic instruments and accessories for visualization and endoscopic manipulation. The HYROS-PRnP clinical investigation was planned to be conducted in a single-center, with a single arm, open-label, and non-randomized design to include 15 patients. This clinical investigation aimed to evaluate the safety and performance of the Bitrack System in patients indicated with robotic-assisted laparoscopic Radical nephrectomy, Partial nephrectomy or Radical Prostatectomy surgeries. The planned visits for this clinical investigation were Baseline (including Screening, Baseline visit, and Informed consent), Procedure, Discharge, 14-Days Follow-up visit (onsite), and 30-Days Follow-up visit (remote). The patient population were adult subjects (between 18 and 90 years old) who had been scheduled for laparoscopic Radical Nephrectomy. Partial Nephrectomy or Radical Prostatectomy. The expected duration of the clinical investigation was 4 months, consisting of approximately 3 months of enrollment plus 1 month of follow-up. The end of the clinical investigation would occur when the last visit of the last enrolled subject was completed.
Interventions
DEVICERobot assisted laparoscopic Radical/simple nephrectomy (RN), Partial nephrectomy (PN) or Radical Prostatectomy (RP).
Three different surgery interventions: 1. Radical Nephrectomy: Complete remove of the kidney; 2. Partial Nephrectomy: Partial remove of a section in the kidney. 3. Radical Prostatectomy: Complete remote of the prostate gland. During each of these procedures removal of regional lymph nodes (lymphadenectomy) and lysis of abdominal lesions may be performed according to patient medical condition and/or surgeon criteria.
Sponsors
Rob Surgical Systems S.L.
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
1. Adult subjects between 18 and 90 years old who have provided written informed consent prior to any clinical investigation related procedures. 2. Subjects who have been scheduled for a laparoscopic Radical/simple Nephrectomy surgery, laparoscopic Partial Nephrectomy or laparoscopic Radical Prostatectomy following the surgeon criteria. 3. Ability and willingness to comply with all study requirements to be evaluated for each study visit.
Exclusion criteria
1. Pregnant or breastfeeding women at the time of the surgery. 2. Subjects with severe concomitant illness that, at PI´s discretion, increases risk of therapeutic interventions or that have been submitted to multiple prior surgeries. 3. Subjects admitted to the hospital due to an emergency situation. 4. Subjects with untreated active infection. 5. Subject with known allergy to some of the device components (i.e., stainless steel, etc.) 6. Subjects not suitable to undergo MIS/MIRS, according to medical criteria. 7. Subjects with life expectancy inferior to 3 months. 8. Subjects with a BMI ≥ 40. 9. Subjects with any contraindication for the use of the Bitrack System and the ESE/NESE instruments, as specified in the Instructions For Use. 10. Subjects with abuses of active substances or with uncontrolled psychiatric disorders. 11. Subjects with severe cardiopulmonary or coronary artery disease, bleeding disorders or that have been submitted to multiple prior operations. 12. Subjects scheduled for surgeries intended to be in direct contact with the heart, the central circulatory system or the central nervous system. 13. Inability to adhere to study-related procedures. 14. Subjects who participate in another trial which may affect the outcome data on this study or the ability to complete the follow up requirements.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lack of Occurrence of a SAE Related to the Use of the Medical Devices Under Investigation During the Intervention | During the procedure | Evaluation of Bitrack System to assist in the accurate control of its compatible ESE/NESE instruments, during the intervention without causing any particular SAE related to the use of the medical devices under investigation. |
| Performance | During the procedure | Estimation of the global performance score: Assessment with a "Surgeon performance scale", that ranges with the minimum score of 1 (Failure) and the maximun score of 5 (Excellent), to confirm that the Bitrack system and ESE/NESE instruments perform as intended during the surgery. This scale is measured by the surgeon after each surgery. |
Countries
Spain
Contacts
PRINCIPAL_INVESTIGATORLluís Peri Cusí, MD
Urology Department, Hospital Clinic of Barcelona
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 64.9 years STANDARD_DEVIATION 13 |
| BMI | 26.1 kg/m2 STANDARD_DEVIATION 3.68 |
| Procedure Type Partial Nephrectomy | 1 Participants |
| Procedure Type Radical Nephrectomy | 9 Participants |
| Procedure Type Radical Prostatectomy | 5 Participants |
| Sex: Female, Male Female | 4 Participants |
| Sex: Female, Male Male | 11 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 15 |
| other Total, other adverse events | 11 / 15 |
| serious Total, serious adverse events | 0 / 15 |
Outcome results
None listed